NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
NewAmsterdam Pharma 12.12M share Secondary priced at $24.50
The deal size was increased to $416.5M from $300M and priced below last closing price of $25.57. Jefferies, Goldman Sachs, Leerink, TD Cowen, ...